Even though CRP, which is the prototype of the pentraxin family [75], together with PTX3 are both considered valid candidates for atherosclerosis, studies to date reported a lack of correlation between their serum levels, suggesting different mediation pathways of the inflammatory process in atherosclerotic plaques. This evidence concerns the gene CRP and atherosclerosis.